May 22, 2012
A Delaware federal judge on Friday barred Mylan Pharmaceuticals Inc. from selling a generic version of Galderma Laboratories Inc.'s rosacea drug Oracea, even though the patent Mylan was found to have infringed was issued after its generic received government approval.
August 26, 2011
A Delaware federal judge on Friday found that Mylan Pharmaceuticals Inc.'s efforts to bring a generic version of the rosacea drug Oracea to the market infringed a valid patent held by Galderma Laboratories Inc.